Gut Microbiome

Gut microbes mediate the synergistic effects of dietary cholesterol and saturated fat in driving fibrosing MASH.

TL;DR

Both dietary cholesterol and saturated fat are required to induce fibrosing MASH in SPF mice whereas germ-free mice are protected, with gut microbes mediating hepatic fibrosis via deoxycholic acid-driven hepatic stellate cell activation.

Key Findings

Both dietary cholesterol and saturated fat together are required to induce fibrosing MASH in specific pathogen-free mice, while germ-free mice are protected from disease.

  • SPF mice fed high-fat, high-cholesterol diets developed fibrosing MASH, whereas neither dietary component alone was sufficient to induce the full disease phenotype.
  • Germ-free mice fed the same high-fat, high-cholesterol diet were protected from fibrosing MASH, demonstrating a necessary role for the gut microbiota.
  • The study used specific pathogen-free (SPF) and germ-free (GF) mouse models to dissect independent and synergistic dietary effects.
  • The findings indicate a synergistic interaction between saturated fat and cholesterol that depends on microbial presence.

Dietary saturated fat and cholesterol individually alter gut microbial community membership, while their combination promotes a distinct microbial composition.

  • Saturated fat alone and cholesterol alone each independently altered gut microbial membership, potentially via altered bile acid metabolism.
  • The combination of saturated fat and cholesterol together promoted a distinct microbial composition that differed from either dietary component alone.
  • The combined diet was associated with an increase in Parasutterella spp., which correlated with hepatic fibrosis.
  • Altered bile acid metabolism was identified as a potential mechanism by which diet shapes microbial community structure.

Parasutterella spp. abundance increased in mice fed the high-fat, high-cholesterol diet and correlated with hepatic fibrosis.

  • Parasutterella spp. were identified as part of the distinct microbial composition promoted by the combination of saturated fat and cholesterol.
  • The abundance of Parasutterella spp. positively correlated with hepatic fibrosis severity.
  • This association suggests Parasutterella spp. may play a role in diet-induced liver fibrogenesis.

Diluted cecal contents from SPF mice fed high-fat, high-cholesterol diets are enriched in deoxycholic acid and activate human hepatic stellate cells in vitro.

  • Cecal contents from SPF mice fed the high-fat, high-cholesterol diet were enriched in deoxycholic acid (DCA), a secondary bile acid produced by gut bacteria.
  • Cecal contents from germ-free mice fed the same diet did not activate human hepatic stellate cells in vitro, consistent with the absence of microbial bile acid metabolism.
  • Activation of human hepatic stellate cells by SPF cecal contents suggests a mechanistic link between dietary lipid-induced microbiota changes and liver fibrogenesis.
  • The in vitro experiment used diluted cecal contents applied to human hepatic stellate cells to model microbiota-liver communication.

Gut microbiota-derived bile acid metabolism, particularly deoxycholic acid production, represents a potential mechanistic pathway linking Western diet components to hepatic stellate cell activation and fibrosis.

  • Deoxycholic acid is a secondary bile acid generated through microbial biotransformation of primary bile acids.
  • The enrichment of DCA in cecal contents from high-fat, high-cholesterol-fed SPF mice, but not GF mice, supports a microbiota-dependent mechanism.
  • Hepatic stellate cell activation is a key driver of liver fibrogenesis, linking microbial metabolites to fibrotic disease progression.
  • The authors propose this pathway as offering 'potential targets for therapeutic interventions against MASLD/MASH.'

MASLD affects approximately one-third of the global population and can progress to MASH with fibrosis, increasing the risk of cirrhosis, hepatocellular carcinoma, and mortality.

  • The global prevalence of MASLD is estimated at approximately one-third of the population.
  • Progression from MASLD to MASH with fibrosis increases the risk of cirrhosis, hepatocellular carcinoma, and mortality.
  • Gut microbes driven by diets high in saturated fat, simple sugar, and cholesterol contribute to disease progression, yet underlying mechanisms remained undefined prior to this study.

What This Means

This research suggests that the combination of two common Western diet components — saturated fat and cholesterol — is necessary to trigger severe liver disease (a condition called fibrosing MASH) in mice, and that gut bacteria play a critical role in this process. When mice lacked any gut microbes entirely (germ-free mice), they were protected from developing the disease even when fed the same unhealthy diet, demonstrating that the microbiome is not just a bystander but an active contributor to liver damage. Neither saturated fat nor cholesterol alone was sufficient to cause the full disease — both were required together, pointing to a synergistic dietary effect mediated by the gut microbiota. The study also found that the combination diet promotes a distinct community of gut bacteria, including a bacterium called Parasutterella, whose abundance correlated with liver scarring (fibrosis). A key proposed mechanism involves bile acids: gut bacteria convert bile acids produced by the liver into a secondary compound called deoxycholic acid (DCA), and fluid from the guts of diet-fed conventional mice — which was enriched in DCA — was able to activate human liver-scarring cells (hepatic stellate cells) in laboratory dishes, while fluid from germ-free mice did not have this effect. This research suggests that the interaction between specific Western dietary fats and gut microbial metabolism — particularly the production of deoxycholic acid — creates conditions that drive liver fibrosis. These findings may help explain why diet-related liver disease progresses in some people and could point toward new therapeutic strategies, such as targeting specific gut bacteria or bile acid pathways, to prevent or treat MASH and its serious complications including cirrhosis and liver cancer.

Have a question about this study?

Citation

Hermanson J, Tolba S, Gazi M, Chrisler E, Kaur M, Sidebottom A, et al.. (2026). Gut microbes mediate the synergistic effects of dietary cholesterol and saturated fat in driving fibrosing MASH.. Gut microbes. https://doi.org/10.1080/19490976.2026.2668121